Perez Daniel R, Kemeny Nancy E, Brown Karen T, Gewirtz Alexandra N, Paty Philip B, Jarnagin William R, D'Angelica Michael I
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
HPB (Oxford). 2014 Aug;16(8):744-8. doi: 10.1111/hpb.12208. Epub 2013 Dec 18.
Hepatic arterial infusion (HAI) chemotherapy is an effective treatment for patients with liver malignancy. Extrahepatic perfusion (EHP) after HAI pump placement requires correction prior to starting chemotherapy. The aim of this study was to define the origin of arterial branches causing EHP in order to determine if alterations in surgical technique during pump placement might prevent EHP.
A prospectively maintained, single-centre HAI database was reviewed for all patients (2008-2011) with EHP. The origin of arterial branches causing EHP was classified anatomically and patient outcomes were analysed.
Of the 327 patients with pumps implanted, 24 evidenced EHP. The arterial branch responsible for EHP perfused the duodenum, pancreas and/or stomach. The branch responsible for EHP arose from the proper hepatic artery (PHA), 1(st) , 2(nd) , or 3(rd) order hepatic artery branches in 7, 10, 5 and 2 patients, respectively. The majority of branches beyond the PHA causing EHP (13/17) originated from the right hepatic artery. In 18 patients, aberrant branches were successfully treated with embolization.
These findings provide the anatomic basis for prevention of up to one-third of the cases of EHP intra-operatively, decreasing the number of patients who will require additional procedures for correction of EHP post-operatively.
肝动脉灌注(HAI)化疗是治疗肝脏恶性肿瘤患者的一种有效方法。在开始化疗前,需要纠正HAI泵置入后的肝外灌注(EHP)。本研究的目的是确定导致EHP的动脉分支的起源,以确定在泵置入过程中手术技术的改变是否可以预防EHP。
对前瞻性维护的单中心HAI数据库中所有出现EHP的患者(2008 - 2011年)进行回顾。对导致EHP的动脉分支起源进行解剖学分类,并分析患者的预后。
在327例植入泵的患者中,24例出现EHP。导致EHP的动脉分支灌注十二指肠、胰腺和/或胃。导致EHP的分支分别起源于肝固有动脉(PHA)、第一、第二或第三级肝动脉分支,各有7例、10例、5例和2例患者。导致EHP的PHA以外的大多数分支(13/17)起源于肝右动脉。在18例患者中,异常分支通过栓塞成功治疗。
这些发现为术中预防高达三分之一的EHP病例提供了解剖学依据,减少了术后需要额外进行EHP纠正手术的患者数量。